Main Directory
Articles 2591
CME 2
eCommerce 0
Medical Web Sites Directory 93
Podcasts 94
Web Design and Hosting 2




Sibutramine May Be Safely Used in High-Risk Patients
Link ID 2866
Title Sibutramine May Be Safely Used in High-Risk Patients
Url http://www.medscape.com/viewarticle/569551?src=rss
Description Sibutramine appears safe and possibly effective for weight management in patients at high risk for cardiovascular disease -- for whom sibutramine is usually contraindicated -- according to a report in the December issue of the European Heart Journal. Reuters Health Information
Category Articles > Diabetes and Endocrinology
Keywords
Date Feb 1, 2008
Contact Name
Email
Write a Review   Add to My Favorite   Refer it to Friend   Report Broken Link  

Average Visitor Rating: 0.00 (out of 5)
Number of ratings: 0 Votes
Visitor Rating

 Other links at Articles > Diabetes and Endocrinology
1. Simvastatin Reduces Insulin Sensitivity in Patients With High Cholesterol
  Although simvastatin improves flow-mediated dilation in hypercholesterolemic patients, the drug reduces adiponectin levels and insulin sensitivity, according to a report in the April issue of Diabetes Care. These effects were not dose-dependent and also did not relate to the magnitude of apolipoprotein B reduction. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology


2. Vitamin D Supplementation May Protect Children From Type 1 Diabetes
  A systematic review and meta-analysis shows that children given additional vitamin D are approximately 30% less likely to have type 1 diabetes in later life vs those not given the supplement. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


3. Panel Discussion
  Learn about the endocannabinoid system’s role in regulating metabolism and body weight as well as new behavioral strategies and pharmacotherapy for achieving weight loss.
Category:   Articles > Diabetes and Endocrinology


4. Obesity Linked to Risk for Colorectal Adenoma
  A retrospective cohort study shows that obesity is associated with the risk for colorectal adenoma, and body weight reduction is suggested to decrease this risk. Medscape Medical News
Category:   Articles > Diabetes and Endocrinology


5. Investigational Agent Taranabant Inhibits Food Intake and Stimulates Metabolism
  Taranabant, a novel cannabinoid 1 (CB1) receptor inverse agonist, induces weight loss by reducing appetite and increasing energy expenditure and fat oxidation, according to a compilation of research data presented in the January issue of Cell Metabolism. Reuters Health Information
Category:   Articles > Diabetes and Endocrinology




Home      New Listings      Hot Listings      Top Rated      Editor Pick      Add a Listing      Update a Listing      Get Rated      Upgrade a Listing
Valid XHTML 1.0 Transitional   Valid CSS